Stealth BioTherapeutics Corp filed its 20-F on Apr 07, 2022 for the period ending Dec 31, 2021. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Stealth BioTherapeutics Corp
Equities
MITO
US85789A1051
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+40.68% | 39.03B | |
-11.17% | 26.86B | |
+14.28% | 26.75B | |
-21.40% | 19.03B | |
+0.96% | 12.28B | |
+25.64% | 12.26B | |
+27.04% | 12.04B |